Sinopharm
1099.HK
#1895
Rank
S$11.47 B
Marketcap
$3.68
Share price
2.90%
Change (1 day)
9.03%
Change (1 year)
The Sinopharm Group is a Chinese pharmaceutical company that researches, develops, produces, sells and markets pharmaceuticals and other health products.

Sinopharm (1099.HK) - Total liabilities

Total liabilities on the balance sheet as of December 2023 : S$50.00 Billion

According to Sinopharm's latest financial reports the company's total liabilities are S$50.00 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Sinopharm - Total liabilities on balance sheet (from 2008 to 2023)

Total liabilities by year

Year Total liabilities Change
2022-12-31S$49.43 B-1.16%
2021-12-31S$50.01 B11.44%
2020-12-31S$44.88 B20.54%
2019-12-31S$37.23 B11.92%
2018-12-31S$33.27 B21.92%
2017-12-31S$27.29 B15.69%
2016-12-31S$23.58 B9.68%
2015-12-31S$21.50 B9.12%
2014-12-31S$19.71 B22.52%
2013-12-31S$16.08 B40.98%
2012-12-31S$11.41 B17.23%
2011-12-31S$9.73 B83.06%
2010-12-31S$5.31 B38.91%
2009-12-31S$3.82 B43.46%
2008-12-31S$2.66 B15.9%
2007-12-31S$2.30 B30.21%
2006-12-31S$1.76 B